ConductScience.org, home

Paper19084813

Atrial-selective effects of chronic amiodarone in the management of atrial fibrillation.

Burashnikov A and 5 others. Heart Rhythm, 2008. Cited by 61 papers, by iCite.

Cite this record

ConductScience Library. Atrial-selective effects of chronic amiodarone in the management of atrial fibrillation. Papers, record 19084813. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19084813

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Atrial-selective effects of chronic amiodarone in the management of atrial fibrillation.
PubMed
Journal
Heart Rhythm
PubMed
Year
2008
PubMed
Publication types
Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
61
iCite
Relative citation ratio, by iCite
1.71
iCite
Revised in PubMed
2025-05-29
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Burashnikov AAlexander
2Di Diego JMJosé M
3Sicouri SSerge
4Ferreiro MMarcela
5Carlsson LLeif
6Antzelevitch CCharles

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AmiodaroneMajor topic
Anti-Arrhythmia AgentsMajor topic
Atrial FibrillationMajor topic
Heart AtriaMajor topic
Administration, Oral
Animals
Atrial Function
Disease Models, Animal
Dogs
Dose-Response Relationship, Drug
Electrocardiography
Follow-Up Studies
Heart Rate
Membrane Potentials
Time Factors
Treatment Outcome

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 HL047678NHLBI NIH HHSUnited StatesR01HL047678PubMed and NIHNIH RePORTER
HL-47687NHLBI NIH HHSUnited StatesS15HL047687PubMed and NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in19084814Does the postrepolarization refractoriness play a role in amiodarone's antiarrhythmic efficacy?https://conductscience.org/library/papers/19084814

Source PubMed

Download CSV of comments and corrections

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116556442Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model.Eur J Pharmacol2006https://conductscience.org/library/papers/16556442PubMed
29395170Chronic amiodarone reduces transmural dispersion of repolarization in the canine heart.J Cardiovasc Electrophysiol1997https://conductscience.org/library/papers/9395170PubMed
312695296Reinduction of atrial fibrillation immediately after termination of the arrhythmia is mediated by late phase 3 early afterdepolarization-induced triggered activity.Circulation2003https://conductscience.org/library/papers/12695296PubMed
47491312Basic concepts in cellular cardiac electrophysiology: Part II: Block of ion channels by antiarrhythmic drugs.Pacing Clin Electrophysiol1995https://conductscience.org/library/papers/7491312PubMed
57782268Acute effects of amiodarone on membrane properties, refractoriness, and conduction in guinea pig papillary muscles.Heart Vessels1995https://conductscience.org/library/papers/7782268PubMed
611343415Late sodium current is a novel target for amiodarone: studies in failing human myocardium.J Mol Cell Cardiol2001https://conductscience.org/library/papers/11343415PubMed
71282594Effects of WAY-123,398, a new class III antiarrhythmic agent, on cardiac refractoriness and ventricular fibrillation threshold in anesthetized dogs: a comparison with UK-68798, E-4031, and dl-sotalol.J Cardiovasc Pharmacol1992https://conductscience.org/library/papers/1282594PubMed
815302796Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties.Circulation2004https://conductscience.org/library/papers/15302796PubMed
917139288Innovative approaches to anti-arrhythmic drug therapy.Nat Rev Drug Discov2006https://conductscience.org/library/papers/17139288PubMed
1018670368Atrial-selective sodium channel blockers: do they exist?J Cardiovasc Pharmacol2008https://conductscience.org/library/papers/18670368PubMed
113409504Mechanisms of depressed conduction from long-term amiodarone therapy in canine myocardium.Circulation1988https://conductscience.org/library/papers/3409504PubMed
1215148061Transmembrane action potential heterogeneity in the canine isolated arterially perfused right atrium: effect of IKr and IKur/Ito block.Am J Physiol Heart Circ Physiol2004https://conductscience.org/library/papers/15148061PubMed
1311973411Chronic and acute effects of dronedarone on the action potential of rabbit atrial muscle preparations: comparison with amiodarone.J Cardiovasc Pharmacol2002https://conductscience.org/library/papers/11973411PubMed
1412649377Amiodarone-induced postrepolarization refractoriness suppresses induction of ventricular fibrillation.J Pharmacol Exp Ther2003https://conductscience.org/library/papers/12649377PubMed
1510466495The M cell: its contribution to the ECG and to normal and abnormal electrical function of the heart.J Cardiovasc Electrophysiol1999https://conductscience.org/library/papers/10466495PubMed
1617765636A practical guide for clinicians who treat patients with amiodarone: 2007.Heart Rhythm2007https://conductscience.org/library/papers/17765636PubMed
1715243307In vivo and in vitro characterization of the novel antiarrhythmic agent SSR149744C: electrophysiological, anti-adrenergic, and anti-angiotensin II effects.J Cardiovasc Pharmacol2004https://conductscience.org/library/papers/15243307PubMed
1814985067In vivo electrophysiological effects of a selective slow delayed-rectifier potassium channel blocker in anesthetized dogs: potential insights into class III actions.Cardiovasc Res2004https://conductscience.org/library/papers/14985067PubMed
193941203Acute and chronic effects of amiodarone on ventricular refractoriness, intraventricular conduction and ventricular tachycardia induction.J Am Coll Cardiol1986https://conductscience.org/library/papers/3941203PubMed
2017785620Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine.Circulation2007https://conductscience.org/library/papers/17785620PubMed

See all 31 referencesDownload CSV of references

Cited by43

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.

PMIDTitleJournalYearIn PapersSource
42631151Personalized in silico modeling of cardiac ion channel variants to predict drug-induced proarrhythmia risk.Front Physiol2026https://conductscience.org/library/papers/42631151PubMed
41944301Causal AI in Cardiac Arrhythmia: From Pattern Recognition to Mechanistic Insight.Clin Cardiol2026https://conductscience.org/library/papers/41944301PubMed
39739528The Value of P-Wave Parameters Changes in Predicting Catheter Ablation Outcomes for Paroxysmal Atrial Fibrillation.Ann Noninvasive Electrocardiol2025https://conductscience.org/library/papers/39739528PubMed
39330335The Role of P Wave Parameters in Predicting Pulmonary Vein Isolation Outcomes for Paroxysmal Atrial Fibrillation: An Observational Cohort Study.J Cardiovasc Dev Dis2024https://conductscience.org/library/papers/39330335PubMed
38619735Extracellular acidification reveals the antiarrhythmic properties of amiodarone related to late sodium current-induced atrial arrhythmia.Pharmacol Rep2024https://conductscience.org/library/papers/38619735PubMed
38146652Effect of Flecainide and Ibutilide Alone and in Combination to Terminate and Prevent Recurrence of Atrial Fibrillation.Circ Arrhythm Electrophysiol2024https://conductscience.org/library/papers/38146652PubMed
37656133Amiodarone prevents wave front-tail interactions in patients with heart failure: an in silico study.Am J Physiol Heart Circ Physiol2023https://conductscience.org/library/papers/37656133PubMed
36310729Widely split P waves in a patient with atrial enlargement and prior atrial flutter catheter ablations.HeartRhythm Case Rep2022https://conductscience.org/library/papers/36310729PubMed
33165131Investigational Anti-Atrial Fibrillation Pharmacology and Mechanisms by Which Antiarrhythmics Terminate the Arrhythmia: Where Are We in 2020?J Cardiovasc Pharmacol2020https://conductscience.org/library/papers/33165131PubMed
32470968Inhibitory Effects of Dronedarone on Small Conductance Calcium Activated Potassium Channels in Patients with Chronic Atrial Fibrillation: Comparison to Amiodarone.Med Sci Monit2020https://conductscience.org/library/papers/32470968PubMed
32453071The Small Conductance Calcium-Activated Potassium Channel Inhibitors NS8593 and UCL1684 Prevent the Development of Atrial Fibrillation Through Atrial-Selective Inhibition of Sodium Channel Activity.J Cardiovasc Pharmacol2020https://conductscience.org/library/papers/32453071PubMed
30306295German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper: impact of molecular mechanisms on clinical arrhythmia management.Clin Res Cardiol2019https://conductscience.org/library/papers/30306295PubMed
25604621Impact of hybrid procedure on P wave duration for atrial fibrillation ablation.J Interv Card Electrophysiol2015https://conductscience.org/library/papers/25604621PubMed
24999375Pulmonary Vein Sleeves as a Pharmacologic Model for the Study of Atrial Fibrillation.Electrofisiol Arritm2010https://conductscience.org/library/papers/24999375PubMed
24874201Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure.Circ Heart Fail2014https://conductscience.org/library/papers/24874201PubMed
24738652Vernakalant for the conversion of atrial fibrillation: the new kid on the block?Ann Noninvasive Electrocardiol2014https://conductscience.org/library/papers/24738652PubMed
23637539Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update.Vasc Health Risk Manag2013https://conductscience.org/library/papers/23637539PubMed
23588622Electrocardiographic P wave changes after thoracoscopic pulmonary vein isolation for atrial fibrillation.J Interv Card Electrophysiol2013https://conductscience.org/library/papers/23588622PubMed
23108433Role of late sodium channel current block in the management of atrial fibrillation.Cardiovasc Drugs Ther2013https://conductscience.org/library/papers/23108433PubMed
22370957Atrial-selective prolongation of refractory period with AVE0118 is due principally to inhibition of sodium channel activity.J Cardiovasc Pharmacol2012https://conductscience.org/library/papers/22370957PubMed

See all 43 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19084813

GET https://conductscience.org/api/papers/v1/19084813/references?page=2